======= SCXB ======= == Gene Information == * **Official Symbol**: SCX * **Official Name**: scleraxis bHLH transcription factor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=642658|642658]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7RTU7|Q7RTU7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SCXB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SCXB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609067|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays an early essential role in mesoderm formation, as well as a later role in formation of somite-derived chondrogenic lineages. {ECO:0000250}. |HLH| |tendon formation| |deltoid tuberosity development| |tendon cell differentiation| |sclerotome development| |tendon development| |positive regulation of gastrulation| |heart valve formation| |Sertoli cell differentiation| |positive regulation of collagen biosynthetic process| |bHLH transcription factor binding| |positive regulation of collagen metabolic process| |replacement ossification| |endochondral ossification| |face morphogenesis| |positive regulation of cartilage development| |regulation of collagen biosynthetic process| |head morphogenesis| |regulation of gastrulation| |positive regulation of embryonic development| |regulation of collagen metabolic process| |body morphogenesis| |collagen fibril organization| |face development| |E-box binding| |skeletal muscle cell differentiation| |heart valve morphogenesis| |heart valve development| |mesoderm formation| |mesoderm morphogenesis| |regulation of cartilage development| |endochondral bone morphogenesis| |cellular response to mechanical stimulus| |chondrocyte differentiation| |somite development| |BMP signaling pathway| |RNA polymerase II distal enhancer sequence-specific DNA binding| |response to BMP| |cellular response to BMP stimulus| |formation of primary germ layer| |bone morphogenesis| |skeletal muscle tissue development| |mesoderm development| |embryonic skeletal system development| |regulation of embryonic development| |skeletal muscle organ development| |male gonad development| |development of primary male sexual characteristics| |cellular response to transforming growth factor beta stimulus| |male sex differentiation| |gastrulation| |response to transforming growth factor beta| |cartilage development| |appendage development| |limb development| |tissue homeostasis| |transmembrane receptor protein serine/threonine kinase signaling pathway| |bone development| |transcription factor complex| |gonad development| |response to mechanical stimulus| |development of primary sexual characteristics| |mesenchyme development| |connective tissue development| |skeletal system morphogenesis| |ossification| |sex differentiation| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |cellular response to environmental stimulus| |cellular response to abiotic stimulus| |multicellular organismal homeostasis| |cellular response to external stimulus| |extracellular matrix organization| |anatomical structure homeostasis| |extracellular structure organization| |sequence-specific DNA binding| |reproductive structure development| |reproductive system development| |DNA-binding transcription activator activity, RNA polymerase II-specific| |supramolecular fiber organization| |muscle structure development| |protein heterodimerization activity| |skeletal system development| |cellular response to growth factor stimulus| |heart development| |response to growth factor| |tissue morphogenesis| |embryonic morphogenesis| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |developmental process involved in reproduction| |epithelial cell differentiation| |enzyme linked receptor protein signaling pathway| |head development| |circulatory system development| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |animal organ morphogenesis| |embryo development| |negative regulation of cell death| |regulation of anatomical structure morphogenesis| |nucleobase-containing compound biosynthetic process| |epithelium development| |response to abiotic stimulus| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11484 * **Expression level (log2 read counts)**: -1.17 {{:chemogenomics:nalm6 dist.png?nolink |}}